Novo Nordisk published another set of data on its popular diabetes and weight-loss treatment and, this time, investors ...

The wildly popular Ozempic drug cuts heart attack, stroke and death risk by nearly 25% in older patients, according to a new ...

Novo Nordisk A/S rose the most in a month after its diabetes blockbuster Ozempic beat Eli Lilly & Co.’s older drug Trulicity ...

Novo Nordisk (NVO) shares rose 6% premarket on Thursday after a real-world study showed its diabetes drug Ozempic ...

In a new study, Ozempic-maker Novo Nordisk shows that its weight loss pill could achieve the similar efficacy as injectables.

Ozempic® is the only GLP-1 RA that has proven risk reduction of cardiovascular and kidney events in people with type 2 diabetes3-6. These results provide the first direct comparison of cardiovascular ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.

Novo Nordisk will cut 9,000 jobs, about 11.5% of its global workforce, as new CEO Maziar Mike Doustdar launches a major ...

Novo Nordisk's Wegovy will soon come in a pill form that's as effective as with a needle. A new study shows Wegovy taken once ...

Novo Nordisk has a strong financial position and portfolio of weight-loss and diabetes treatments. See why NVO’s stock dip ...

Canadians now have a comprehensive, convenient home delivery option for Ozempic® and Wegovy® prescriptions MISSISSAUGA, ON, ...

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 ...